The physiological landscape of Long COVID, ME/CFS, and related dysautonomias is heavily characterized by a profound, unyielding state of oxidative stress
Exendin-4 became the chemical scaffold for exenatide, and on April 28, 2005, the FDA approved exenatide (Byetta) for type 2 diabetes the first GLP-1 receptor agonist ever marketed
2% glutathione, vitamin C, and kojic acid are added
Ferroptosis inducers such as erastin obstruct this route by inhibiting SLC7A11, while concurrently activating mitochondrial VDACs, upregulating ACSL4, and indirectly stimulating p53
Remedy Meds accepts cash only, so there is no insurance
Mazdutide and Tirzepatide are both powerful tools in the fight against type 2 diabetes and obesity